Selection with a regulated cell growth switch increases the likelihood of expression for a linked gamma-globin gene.

[1]  Licheng Zeng,et al.  Successful correction of the human beta-thalassemia major phenotype using a lentiviral vector. , 2004, Blood.

[2]  M. Weinreich,et al.  Modulating erythrocyte chimerism in a mouse model of pyruvate kinase deficiency. , 2004, Blood.

[3]  S. Gerson,et al.  In vivo selection of MGMT(P140K) lentivirus-transduced human NOD/SCID repopulating cells without pretransplant irradiation conditioning. , 2003, The Journal of clinical investigation.

[4]  A. Nienhuis,et al.  Successful treatment of murine beta-thalassemia using in vivo selection of genetically modified, drug-resistant hematopoietic stem cells. , 2003, Blood.

[5]  C. von Kalle,et al.  Pharmacologically regulated in vivo selection in a large animal. , 2002, Blood.

[6]  G. Stamatoyannopoulos,et al.  Development of virus vectors for gene therapy of beta chain hemoglobinopathies: flanking with a chromatin insulator reduces gamma-globin gene silencing in vivo. , 2002, Blood.

[7]  David I. K. Martin,et al.  Transcriptional Interference by Independently Regulated Genes Occurs in Any Relative Arrangement of the Genes and Is Influenced by Chromosomal Integration Position , 2002, Molecular and Cellular Biology.

[8]  A. Belmaaza,et al.  Promoter suppression in cultured mammalian cells can be blocked by the chicken beta-globin chromatin insulator 5'HS4 and matrix/scaffold attachment regions. , 2001, Journal of molecular biology.

[9]  J. Ihle,et al.  Membrane localization is not required for Mpl function in normal hematopoietic cells. , 2001, Blood.

[10]  J. Ellis,et al.  Silencing of gene expression: implications for design of retrovirus vectors , 2001, Reviews in medical virology.

[11]  I. Meeus,et al.  In vivo silencing of the human gamma-globin gene in murine erythroid cells following retroviral transduction. , 2000, Blood cells, molecules & diseases.

[12]  C. A. Blau,et al.  In vivo selection using a cell-growth switch , 2000, Nature Genetics.

[13]  G. Stamatoyannopoulos,et al.  A chromatin insulator protects retrovirus vectors from chromosomal position effects. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[14]  S. Rivella,et al.  The cHS4 Insulator Increases the Probability of Retroviral Expression at Random Chromosomal Integration Sites , 2000, Journal of Virology.

[15]  B. Wood,et al.  Expansion of genetically modified primary human hemopoietic cells using chemical inducers of dimerization. , 2000, Blood.

[16]  D. Kohn,et al.  Improved expression in hematopoietic and lymphoid cells in mice after transplantation of bone marrow transduced with a modified retroviral vector. , 1999, Blood.

[17]  G. Stamatoyannopoulos,et al.  Analysis of gamma-globin expression cassettes in retrovirus vectors. , 1999, Human gene therapy.

[18]  G. Stamatoyannopoulos,et al.  Stem Cell Gene Therapy for the β‐Chain Hemoglobinopathies: Problems and Progress a , 1999 .

[19]  R. Ashmun,et al.  In vivo selection of retrovirally transduced hematopoietic stem cells , 1998, Nature Medicine.

[20]  C. A. Blau,et al.  Targeted expansion of genetically modified bone marrow cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[21]  S. Rivella,et al.  Genetic treatment of severe hemoglobinopathies: the combat against transgene variegation and transgene silencing. , 1998, Seminars in hematology.

[22]  H. Raftopoulos,et al.  Long-Term Transfer and Expression of the Human β-Globin Gene in a Mouse Transplant Model , 1997 .

[23]  K. Peterson,et al.  A proliferation switch for genetically modified cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[24]  F. Pedersen,et al.  Lack of correlation between basal expression levels and susceptibility to transcriptional shutdown among single-gene murine leukemia virus vector proviruses , 1994, Journal of virology.

[25]  S. Thein,et al.  Immunochemical estimation of haemoglobin types in red blood cells by FACS analysis , 1994, British journal of haematology.

[26]  J. Sanes,et al.  The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos , 1991, Molecular and cellular biology.

[27]  G. Stamatoyannopoulos,et al.  Developmental regulation of fetal to adult globin gene switching in human fetal erythroid x mouse erythroleukemia cell hybrids. , 1991, Developmental biology.

[28]  S. Karlsson,et al.  Combination of interleukins 3 and 6 preserves stem cell function in culture and enhances retrovirus-mediated gene transfer into hematopoietic stem cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Miller Ad,et al.  Improved Retroviral Vectors for Gene Transfer and Expression , 1989 .

[30]  S. Goff,et al.  A safe packaging line for gene transfer: separating viral genes on two different plasmids , 1988, Journal of virology.

[31]  M. Emerman,et al.  Quantitative analysis of gene suppression in integrated retrovirus vectors , 1986, Molecular and cellular biology.

[32]  M. Steinmetz,et al.  IL3-dependent mouse clones that express B-220 surface antigen, contain ig genes in germ-line configuration, and generate B lymphocytes in vivo , 1985, Cell.

[33]  M. Emerman,et al.  Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism , 1984, Cell.

[34]  C. Eaves,et al.  Erythropoietin (Ep) dose-response curves for three classes of erythroid progenitors in normal human marrow and in patients with polycythemia vera , 1978 .

[35]  P. Houghton,et al.  Protection and in vivo selection of hematopoietic stem cells using temozolomide, O6-benzylguanine, and an alkyltransferase-expressing retroviral vector. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.